Kenneth Vega

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects one in four people globally and is the primary cause of chronic liver disease. The cornerstone of treatment focuses on lifestyle modifications, including weight loss, diet, and exercise…

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects one in four people globally and is the primary cause of chronic liver disease. MAFLD is associated with a nearly 1.5-fold to 2-fold increased risk of developing GI cancers…